middle.news
Argent BioPharma Secures Exclusive Five-Year Aquiol Licensing for Global Dermocosmetics
9:06am on Monday 25th of May, 2026 AEST
•
Healthcare
Read Story
Argent BioPharma Secures Exclusive Five-Year Aquiol Licensing for Global Dermocosmetics
9:06am on Monday 25th of May, 2026 AEST
Key Points
Exclusive worldwide license for Aquiol™ in dermatology cosmetics
Five-year agreement with fixed and revenue-linked royalties
Expansion of drug delivery tech into dermocosmetics
Production partnership with Slovenian firm NutraMind
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE